Weight Maintenance – Alveus ALV-101-1
Weight Maintenance Study
EXPLORING OPTIONS FOR MAINTAINING YOUR WEIGHT AFTER TREATMENT WITH SEMAGLUTIDE?
Take part in PRESERVE.
This clinical research study aims to find out
whether the investigational study drug ALV-100
maintains weight loss after stopping semaglutide. The study drug is designed to be taken on a monthly basis.
You may be eligible if you:
- Are between 18 and 75 years old
- Have lost at least 10% of your weight with semaglutide for weight management for at least 3 months
- Have been on the same dose of semaglutide for at least 3 months
- Have a BMI of at least 27 kg/m2
- Are willing to maintain your current general diet and physical activity routine throughout the clinical research study
There are other requirements to participate.
Call us or complete the form and our team will reach out soon to help determine your eligibility.
- Michigan: 248-282-3640
- California: 619-489-5613
